HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Whereas HER2 amplification is a well-known phenomenon in breast tumours, its frequency and clinical importance in ovarian cancer have not been established. The aim of the study was to compare the frequency of HER2 amplification in hereditary (BRCA-positive) and sporadic (BRCA-negative) ovarian tumou...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Brożek, Izabela, Kardaś, Iwona, Ochman, Karolina, Dębniak, Jarosław, Stukan, Maciej, Ratajska, Magdalena, Morzuch, Lucyna, Emerich, Janusz, Limon, Janusz
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2006
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401919/
https://ncbi.nlm.nih.gov/pubmed/20223002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1897-4287-4-1-39
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk